Validation of PD Adequest 2.0 for pediatric dialysis patients

Citation
Ba. Warady et al., Validation of PD Adequest 2.0 for pediatric dialysis patients, PED NEPHROL, 16(3), 2001, pp. 205-211
Citations number
28
Categorie Soggetti
Pediatrics
Journal title
PEDIATRIC NEPHROLOGY
ISSN journal
0931041X → ACNP
Volume
16
Issue
3
Year of publication
2001
Pages
205 - 211
Database
ISI
SICI code
0931-041X(200103)16:3<205:VOPA2F>2.0.ZU;2-D
Abstract
Kinetic modeling has proven to be a valuable tool for peritoneal dialysis ( PD) prescription in adult PD patients. The clinical application of this pro cedure has rarely been studied in children. We therefore evaluated the PD A dequest 2.0 for Windows program (Baxter Healthcare Co., Deerfield, IL) as a prescription aid for the management of pediatric PD patients by comparing the measured and predicted PD clearances, total drain volumes, and net ultr afiltration in 34 children (15 males) (mean age 10.9 +/-6.0 years) receivin g long-term PD. In each case, a 4-h peritoneal equilibration test was condu cted with a standardized test exchange volume of 1100 ml/m(2) BSA. A total of 43 24-h dialysate (plus urine in 12) collections were analyzed. The leve ls of agreement between measured and predicted values for weekly peritoneal and total urea Kt/N, weekly peritoneal and total creatinine clearance, dai ly drain volume, net ultrafiltration and daily peritoneal urea and creatini ne mass removal were assessed with correlation coefficients (r(c)) and Blan d-Altman limits of agreement. The study revealed that there is a basic leve l of agreement between measured and modeled values for solute removal and t otal drain volume, with correlation coefficients ranging from 0.75 to 0.98. In contrast, the r(c) for net ultrafiltration was only 0.34. The majority (75%) of patients had modeled urea and creatinine clearances that were with in 20% of their measured values. These data suggest that the PD Adequest 2. 0 for Windows program can predict urea and creatinine clearances with reaso nable accuracy in pediatric PD patients, making it a valuable resource in p rescription management.